Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000313corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846173011625902080
collection DOAJ
format Article
id doaj-art-23a53193d2f74c31bd765e10906bacb4
institution Kabale University
issn 2051-1426
language English
publishDate 2020-05-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-23a53193d2f74c31bd765e10906bacb42024-11-08T17:40:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-05-018110.1136/jitc-2019-000313corr1Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access programhttps://jitc.bmj.com/content/8/1/e000313corr1.full
spellingShingle Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
Journal for ImmunoTherapy of Cancer
title Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
title_full Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
title_fullStr Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
title_full_unstemmed Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
title_short Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
title_sort correction efficacy and safety of avelumab treatment in patients with metastatic merkel cell carcinoma experience from a global expanded access program
url https://jitc.bmj.com/content/8/1/e000313corr1.full